Gynecomastia can be genetic, but most cases are not caused by a single inherited gene. The condition, which involves enlargement of breast tissue in males, has a strong hormonal basis, and several genetic conditions directly disrupt the hormone balance that triggers it. At the same time, the majority of cases, particularly during puberty, are classified as idiopathic, meaning no clear genetic or environmental cause is identified. About 90% of prepubertal and juvenile cases fall into this category.
How Hormones Drive Breast Tissue Growth
Every case of gynecomastia, genetic or not, comes down to the same basic mechanism: the ratio of estrogen activity to androgen activity in breast tissue tips toward estrogen. When free estrogen is relatively high compared to free testosterone, breast tissue grows. This can happen because the body produces too much estrogen, too little testosterone, or because the cells that should respond to testosterone fail to do so. Genetic conditions cause gynecomastia by disrupting one or more of these steps.
Androgen Receptor Gene Mutations
One well-documented genetic cause involves mutations in the androgen receptor (AR) gene, located on the X chromosome. This gene provides the blueprint for a protein that allows cells throughout the body to respond to testosterone. When a mutation reduces the receptor’s function, cells become partially or fully resistant to androgens, even when testosterone levels in the blood are normal or high. This is called androgen insensitivity.
Partial androgen insensitivity syndrome (PAIS) affects roughly 1 in 20,000 males. In milder cases, the external genitalia appear completely normal, and the first sign of a problem may be breast development during puberty. The mechanism works like this: the androgen receptor in the brain’s hypothalamus doesn’t function properly, so the normal feedback loop that regulates hormone production is impaired. The pituitary gland keeps signaling for more testosterone, and the excess testosterone gets converted into estradiol (a form of estrogen) through a process called aromatization. The result is elevated estrogen driving breast tissue growth.
Because the AR gene sits on the X chromosome, males (who have only one X) are affected by a single copy of the mutation. Mothers carry the mutation without symptoms and pass it to roughly half their sons.
Aromatase Excess Syndrome
A rarer but striking genetic cause is aromatase excess syndrome (AEXS), caused by gain-of-function mutations in the CYP19A1 gene. This gene controls aromatase, the enzyme responsible for converting androgens into estrogens. When the gene is overactive, the body converts far too much testosterone into estrogen.
The numbers are dramatic. In boys with AEXS, 16 to 59% of circulating androstenedione (an androgen precursor) gets converted to estrone, compared to a tiny fraction in unaffected males. That represents a 15- to 50-fold increase in conversion. Testosterone-to-estradiol conversion is similarly elevated, roughly 50 times normal levels. The result is estrogen excess and androgen depletion at the same time.
AEXS follows an autosomal dominant inheritance pattern, meaning a child needs only one copy of the mutated gene from one parent to be affected. Researchers have documented families where affected males across three generations developed prepubertal gynecomastia. Twelve distinct types of CYP19A1 mutations have been identified across 15 families so far. One important clinical detail: about 20% of AEXS patients have normal estradiol levels on blood tests because estrone, not estradiol, is the primary estrogen produced. A normal estradiol result does not rule out this condition.
Klinefelter Syndrome
Klinefelter syndrome is the most common chromosomal condition linked to gynecomastia. Males with Klinefelter have an extra X chromosome (47,XXY instead of the typical 46,XY), and up to 80% develop gynecomastia. The extra chromosome leads to primary testicular failure, which means the testes produce low or low-normal testosterone. On top of that, aromatase activity is increased, so more of the limited testosterone gets converted to estradiol. The combination of low androgen production and enhanced estrogen conversion creates exactly the hormonal environment that promotes breast tissue growth.
Klinefelter syndrome occurs in about 1 in 600 male births, making it relatively common compared to the single-gene conditions described above. Many men with Klinefelter are not diagnosed until adulthood, sometimes during evaluation for infertility or persistent gynecomastia.
Kennedy Disease
Kennedy disease (spinal and bulbar muscular atrophy) is a neuromuscular condition caused by a repeat expansion in the androgen receptor gene. Unlike the point mutations that cause androgen insensitivity syndrome, this involves a long stretch of repeated DNA within the same gene. The expanded repeat both damages motor neurons and reduces normal androgen receptor function. The partial androgen insensitivity that results can cause gynecomastia, reduced fertility, and erectile dysfunction alongside the progressive muscle weakness that defines the disease.
How Common Is Gynecomastia Overall?
Gynecomastia is extremely common at certain life stages, which is important context for understanding the genetic question. It appears in 60 to 90% of newborns (due to maternal estrogen exposure), 50 to 60% of adolescents, and up to 70% of men aged 50 to 69. The vast majority of these cases resolve on their own or are linked to normal hormonal fluctuations, medications, or other non-genetic factors.
Among prepubertal boys, roughly 90% of gynecomastia cases are classified as idiopathic. Researchers recommend chromosomal and genetic testing in these cases precisely because the underlying cause is so often unclear. Some proportion of idiopathic cases likely have a genetic component that current testing methods haven’t identified yet, but there are no reliable estimates of how large that proportion is.
When Genetics Are Worth Investigating
Certain patterns raise the likelihood of a genetic cause. Gynecomastia that appears before puberty is unusual and warrants a thorough workup. Breast development that persists well past mid-puberty (beyond age 17 or so) rather than resolving on its own is another signal. A family history of gynecomastia across multiple generations, particularly if it appeared at young ages, points toward an inherited condition like aromatase excess syndrome. And gynecomastia accompanied by small testes, tall stature, or infertility may suggest Klinefelter syndrome.
Genetic testing in these scenarios typically includes chromosomal analysis (to check for Klinefelter) and, if hormonal profiles are abnormal, targeted gene sequencing of the androgen receptor or CYP19A1 genes. Identifying a genetic cause matters because it can change the treatment approach and has implications for other family members.